ROSHNI CHANGELA: Open Payments
NPI 1669085874 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,806 in 141 payments from 17 companies in 2025. Trend: 2023 $277 · 2024 $1,239 · 2025 $2,806
Food & beverage: $2,716Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $479 |
| Arcutis Biotherapeutics, Inc. | 19 | $360 |
| Janssen Biotech, Inc. | 10 | $271 |
| Novartis Pharmaceuticals Corporation | 19 | $268 |
| Incyte Corporation | 11 | $228 |
| GENZYME CORPORATION | 9 | $227 |
| UCB, Inc. | 10 | $198 |
| Lilly USA, LLC | 8 | $177 |
| Amgen Inc. | 5 | $122 |
| E.R. Squibb & Sons, L.L.C. | 6 | $103 |
Products named: Zoryve, TREMFYA, DUPIXENT, SKYRIZI, COSENTYX, OPZELURA, Bimzelx, TALTZ.
Industry payments across WA — which companies pay providers there.
